Conclusion of Non-Exclusive Drug Discount Agreements according to § 130a Paragraph 8 SGB V via an Open-House Model for the Active Ingredient Formoterol/Aclidinium Bromide (WHO ATC Code: R03AL05)
This tender has expired
The submission deadline for this tender has passed. It is no longer accepting bids.
About This Opportunity
TranslatedThis tender concerns the establishment and management of non-exclusive drug discount agreements, operating under an open-house model, as stipulated by § 130a Paragraph 8 of the German Social Code Book V (SGB V). The focus is specifically on the active ingredient Formoterol/Aclidinium Bromide, identified by the WHO Anatomical Therapeutic Chemical (ATC) code R03AL05. The objective is to secure favorable pricing and supply conditions for this specific pharmaceutical product within the German healthcare system. The open-house model allows multiple pharmaceutical manufacturers or distributors to participate and conclude agreements, fostering competition and potentially leading to cost savings for statutory health insurance funds. Key requirements likely involve demonstrating the ability to meet quality standards, ensuring reliable supply chains, and offering competitive pricing for the specified medication. The agreements will aim to regulate the rebates and conditions under which the drug is supplied to healthcare providers and pharmacies, thereby contributing to the cost-effectiveness of pharmaceutical provision. This procurement process is crucial for managing pharmaceutical expenditure and ensuring access to essential medicines while maintaining financial sustainability for the statutory health insurance system in Germany. Further details regarding specific contractual obligations, performance metrics, and eligibility criteria are expected to be outlined in the full tender documentation.
This is a supplies contract in the health and medical services sector, with a focus on Pharmaceuticals. Located in Germany, Europe, this opportunity is open to firms and consortiums. Proposals must be submitted before June 30, 2026.
Published through TED - Tenders Electronic Daily (EU), a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. Interested parties should review the full documentation on the original source before submitting their proposal.
Description
Original language: GermanThis tender, originating from Germany and published on the TED platform, concerns the conclusion of discount agreements for pharmaceuticals under Section 130a, Paragraph 8 of the German Social Code Book V (SGB V). The procurement is specifically focused on the active substance Formoterol/Aclidinium bromide, identified by the ATC code R03AL05. The contracting authority is seeking to establish an "open-house model" for these agreements.
This type of tender typically involves pharmaceutical manufacturers or their authorized representatives submitting proposals for volume-based rebates on the specified medicinal product. The objective is to negotiate cost-saving agreements that benefit the statutory health insurance system in Germany. Bidders will likely be required to demonstrate their capacity to supply the drug and adhere to the terms and conditions of the SGB V framework. Key elements of such tenders often include detailed proposals on rebate structures, the volume of product to be supplied, and compliance with regulatory and quality standards applicable to pharmaceuticals in the European Union. The open-house model suggests a framework where eligible manufacturers can join the agreement under pre-defined conditions, fostering competition and ensuring access to essential medicines while managing healthcare expenditure. Interested parties should review the full tender documentation for specific submission requirements and eligibility criteria.
Data provenance
This notice is sourced from TED - Tenders Electronic Daily (EU) and was originally published on March 11, 2025. Last refreshed 14 days ago. Original language: German. BidsFactory mirrors official procurement notices and links back to the source for full legal text.
About AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen
AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen has issued 36 procurement notices on BidsFactory, including 30 currently open and 2 awarded contracts. Activity concentrates in Health & Medical, General Supplies & Services, and Water & Sanitation. All notices are published for Germany. Notices are distributed via TED - Tenders Electronic Daily (EU) and DÖE Bekanntmachungsservice (Germany). Most recent publication: June 9, 2026.
Frequently asked questions about this tender
Where will the contract be performed?
The contract is for delivery in Germany. Foreign bidders should review local registration, taxation, and any in-country presence requirements before submitting.
How can I submit a bid?
Visit TED - Tenders Electronic Daily (EU) to access the full notice, required documents, and submission instructions provided by the contracting authority.
When does this tender close?
The submission deadline is June 30, 2026. Proposals must be received by the contracting authority before that date.
Who is the contracting authority?
This notice was issued by AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen in Germany. The authority is responsible for evaluating bids, awarding the contract, and managing performance.
What type of contract is this?
This is a Supplies contract in the Health & Medical sector. The classification helps bidders match the opportunity to their qualifications and registered scope of supply.
Find tenders like this automatically
Set up alerts and filters that match your business — never miss a relevant opportunity again.